GO
Loading...

Pfizer Inc

More

  • Midday Glance: Pharmaceuticals companies Friday, 22 Aug 2014 | 1:22 PM ET

    Baxter International Inc. fell$. 57 or. 8 percent, to $75.23. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $50.15. Hospira fell$. 13 or. 2 percent, to $54.61.

  • Final Glance: Pharmaceuticals companies Thursday, 21 Aug 2014 | 6:08 PM ET

    Baxter International Inc. rose$. 55 or. 7 percent, to $75.80. Bristol-Myers Squibb Co. fell$. 05 or. 1 percent, to $49.99. Hospira fell$. 17 or. 3 percent, to $54.74.

  • FDA clears Eliquis for new use against blood clots Thursday, 21 Aug 2014 | 3:10 PM ET

    WASHINGTON— Bristol-Myers Squibb and Pfizer said Thursday that federal regulators have expanded approval of their blood thinner Eliquis to treat two types of dangerous blood clots. The Food and Drug Administration cleared the drug for patients suffering from or at risk of deep vein thrombosis and pulmonary embolism.

  • Midday Glance: Pharmaceuticals companies Thursday, 21 Aug 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 71 or. 9 percent, to $75.96. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $49.92. Hospira fell$. 12 or. 2 percent, to $54.79.

  • Most active New York Stock Exchange-traded stocks Thursday, 21 Aug 2014 | 1:22 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Bank of America Corp. rose 2.6 percent to $15.92 with 71,947,500 shares traded. Citigroup Inc. rose 1.5 percent to $50.56 with 8,811,400 shares traded.

  • Lilly psoriasis drug fares well in late-stage test Thursday, 21 Aug 2014 | 8:55 AM ET

    INDIANAPOLIS— Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

  • Final Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 12 or. 2 percent, to $75.25. Bristol-Myers Squibb Co. fell$. 26 or. 5 percent, to $50.04. Hospira rose$. 99 or 1.8 percent, to $54.91.

  • Most active New York Stock Exchange-traded stocks Wednesday, 20 Aug 2014 | 1:49 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. American Eagle Outfitters Inc. rose 12.0 percent to $12.98 with 27,989,700 shares traded. Bank of America Corp. rose. 5 percent to $15.52 with 57,060,700 shares traded.

  • Midday Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 1:49 PM ET

    Baxter International Inc. rose$. 11 or. 1 percent, to $75.24. Bristol-Myers Squibb Co. fell$. 18 or. 4 percent, to $50.12. Hospira rose$. 70 or 1.3 percent, to $54.62.

  • Early Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 12:21 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $74.78. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $50.14. Hospira rose$. 45 or. 8 percent, to $54.37.

  • Final Glance: Pharmaceuticals companies Tuesday, 19 Aug 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 08 or. 1 percent, to $75.13. Bristol-Myers Squibb Co. rose$. 31 or. 6 percent, to $50.30. Hospira fell $1.56 or 2.8 percent, to $53.92.

  • Most active New York Stock Exchange-traded stocks Tuesday, 19 Aug 2014 | 4:03 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 5 percent to $34.48 with 20,342,400 shares traded. Advanced Micro Devices Inc. rose 1.4 percent to $4.27 with 23,124,000 shares traded.

  • Midday Glance: Pharmaceuticals companies Tuesday, 19 Aug 2014 | 4:03 PM ET

    Baxter International Inc. rose$. 01 or percent, to $75.22. Bristol-Myers Squibb Co. fell$. 15 or. 3 percent, to $49.84. Hospira fell $1.18 or 2.1 percent, to $54.30.

  • UPDATE 1-U.S. clears AstraZeneca over heart drug trial Tuesday, 19 Aug 2014 | 3:24 AM ET

    LONDON, Aug 19- The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects.

  • U.S. clears AstraZeneca over heart drug trial Tuesday, 19 Aug 2014 | 2:31 AM ET

    LONDON, Aug 19- AstraZeneca said on Tuesday the U.S. government was closing a probe into a major clinical trial used to win marketing approval for its new heart drug Brilinta and no further action was planned.

  • Most active New York Stock Exchange-traded stocks Monday, 18 Aug 2014 | 6:02 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 3 percent to $34.65 with 18,327,500 shares traded. Advanced Micro Devices Inc. rose 1.9 percent to $4.21 with 45,320,400 shares traded.

  • Final Glance: Pharmaceuticals companies Monday, 18 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 80 or 1.1 percent, to $75.21. Bristol-Myers Squibb Co. rose$. 31 or. 6 percent, to $49.99. Hospira rose$. 46 or. 8 percent, to $55.48.

  • Early Glance: Pharmaceuticals companies Monday, 18 Aug 2014 | 10:29 AM ET

    Baxter International Inc. rose$. 81 or 1.1 percent, to $75.22. Bristol-Myers Squibb Co. rose$. 13 or. 3 percent, to $49.81. Hospira rose$. 76 or 1.4 percent, to $55.78.

  • LOS ANGELES, Aug 17- Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies.

  • NORWICH, England, Aug 17- Pampering leafcutter ants with fragrant rose petals and fresh oranges may seem an unlikely way to rescue modern medicine, but scientists at a lab in eastern England think it's well worth trying.